首页|ALBI、PALBI评分对脓毒症患者预后的预测价值分析

ALBI、PALBI评分对脓毒症患者预后的预测价值分析

扫码查看
目的 探讨白蛋白-胆红素(ALBI)、血小板-白蛋白-胆红素(PALBI)评分对脓毒症患者预后的预测价值,以期为临床决策的制定提供参考.方法 选取2017年8月—2021年12月重庆某医院收治的163例脓毒症患者作为研究对象,根据患者28 d内的随访情况,将其分为存活组(n=82)、死亡组(n=81).采集治疗前患者的实验室指标,分别计算ALBI、PAL-BI评分;采用受试者工作特征(ROC)曲线评估ALBI、P ALBI评分对脓毒症患者预后的预测价值;采用多因素logistic回归分析探讨脓毒症患者预后的影响因素.结果 死亡组患者的ALBI、P ALBI评分分别为(-1.48±0.12)分、(-1.75±0.10)分,明显高于存活组的(-2.07±0.09)分、(-2.02±0.08)分(P<0.05).ALBI、PALBI评分预测脓毒症患者预后的曲线下面积(AUC)分别为 0.783(95%CI:0.738~0.833)、0.841(95%CI:0.796~0.891),二者联合预测的 AUC 为0.926(95%CI:0.881~0.976).2组患者的性别、年龄、身体质量指数、心血管疾病患病人数比例、内分泌疾病患病人数比例、肾脏疾病患病人数比例、消化系统疾病患病人数比例、白细胞计数、血红蛋白、动脉血氧分压(PaO2)、谷草转氨酶(AST)、谷丙转氨酶(ALT)比较,差异均无统计学意义(P>0.05);死亡组患者急性生理学与慢性健康状况评分Ⅱ(APACHE Ⅱ)、序贯器官衰竭评估(SOFA)评分、C反应蛋白(CRP)、总胆红素(TBIL)水平高于存活组(P<0.05),血小板计数(PLT)、白蛋白(ALB)水平低于存活组(P<0.05).多因素回归分析结果显示:高APACHE Ⅱ评分(OR=2.494,95%CI:1.372~4.535)、高 TBIL 水平(OR=3.184,95%CI:1.687~6.008)、高 ALBI 评分(OR=3.854,95%CI:2.082~7.131)、高 PALBI 评分(OR=3.536,95%CI:1.859~6.725)是脓毒症患者预后的危险因素(P<0.05).结论 ALBI、PALBI评分对脓毒症患者的预后有较好的预测价值,二者均是脓毒症患者预后的影响因素,联合检测对脓毒症患者预后的预测价值更高.
ALBI and PALBI scores for predicting prognosis in sepsis patients
Objective To explore the predictive value of Albumin-Bilirubin(ALBI)and Platelet-Albumin-Bilirubin(PALBI)scores for the prognosis of sepsis patients,aiming to provide a reference for clinical decision-making.Methods A total of 163 sepsis patients admitted to a hospital in Chongqing from August 2017 to December 2021 were selected as the study par-ticipants,who were assigned to a survival group(n=82)and a death group(n=81)based on their outcomes within 28 days.Pre-treatment laboratory indicators of the patients were collected.ALBI and PALBI scores were calculated respective-ly.The predictive value of ALBI and PALBI scores for the prognosis of sepsis patients was evaluated using the Receiver Op-erating Characteristic(ROC)curve.A multivariate logistic regression analysis was used to explore the influencing factors of the prognosis of sepsis patients.Results The ALBI and PALBI scores of the death group were(-1.48±0.12)points and(-1.75±0.10)points,respectively,which were significantly higher than those of the survival group,(-2.07±0.09)points and(-2.02±0.08)points(P<0.05).The area under the curve(AUC)of ALBI and PALBI scores for predicting the prognosis of sepsis patients were 0.783(95%CI:0.738-0.833)and 0.841(95%CI:0.796-0.891),respectively,and the combined prediction AUC was 0.926(95%CI:0.881-0.976).No statistically significant differences were ob-served in gender,age,body mass index,proportion of patients with cardiovascular diseases,endocrine diseases,kidney dis-eases,digestive system diseases,white blood cell count,hemoglobin,arterial blood oxygen partial pressure(PaO2),aspar-tate aminotransferase(AST),and alanine aminotransferase(ALT)between the two groups(P>0.05).The Acute Physi-ology and Chronic Health Evaluation Ⅱ(APACHE Ⅱ)score,Sequential Organ Failure Assessment(SOFA)score,C-re-active protein(CRP),and total bilirubin(TBIL)levels in the death group were significantly higher than those in the survival group(P<0.05),while platelet count(PLT)and albumin(ALB)levels were significantly lower in the death group(P<0.05).The multivariate regression analysis showed that high APACHE Ⅱ score(OR=2.494,95%CI:1.372-4.535),high TBIL level(OR=3.184,95%CI:1.687-6.008),high ALBI score(OR=3.854,95%CI:2.082-7.131),and high PALBI score(OR=3.536,95%CI:1.859-6.725)were risk factors for the prognosis of sepsis patients(P<0.05).Con-clusion ALBI and PALBI scores have good predictive value for the prognosis of sepsis patients,both are influencing factors for the prognosis of these patients,and combined detection has a higher predictive value for the prognosis.

Albumin-bilirubin scorePlatelet-albumin-bilirubin scoreSepsisPrognosis

雷佳佳、邓利艳、王洪锦、刘秋宇、刘红玲、陶武

展开 >

重庆医科大学附属永川医院重症医学科,重庆 402177

重庆三峡医药高等专科学校附属人民医院重症医学科,重庆 404120

白蛋白-胆红素评分 血小板-白蛋白-胆红素评分 脓毒症 预后

2024

保健医学研究与实践
西南大学

保健医学研究与实践

CSTPCD
影响因子:0.512
ISSN:1673-873X
年,卷(期):2024.21(8)